Skip to Primary Navigation

Trump administration health leadership on life support

A photo of the lawn sign at FDA headquarters with a blue sky above it.
Photo: Sarah Silbiger/Getty Images

A leadership vacuum at the FDA hits crisis mode as the Trump administration scrambles to replace departing senior officials and restore stability.

With Marty Makary out as top regulator after more than a year of internal upheaval, the US Food and Drug Administration (FDA) is confronting a leadership gap bordering on a crisis of the Trump administration’s own making. The administration is now scrambling to accelerate efforts to recruit a new

Leadership

Get full access, free for a month

This is a Premium article. Start your 28-day free trial to continue reading and access all content on GRIP – no payment details required.

What’s included:

  • Every new article, plus our 5,000+ archive
  • Daily regulatory insight and guidance
  • Exclusive interviews and in-depth analysis
  • Coverage of industry-leading events and conferences
  • All podcasts and videos, featuring industry experts
  • The full set of Rules Navigator tools
  • An ad-free experience